The impact of the perception of treatment choice on satisfaction with treatment, experienced chemotherapy burden and current quality of life

por Jansen, S J T, Otten, W, van de Velde, C J H, Nortier, J W R, Stiggelbout, A M
Publicado 2004

The in- or exclusion of non-breast cancer related death and contralateral breast cancer significantly affects estimated outcome probability in early breast cancer

por Nout, R. A., Fiets, W. E., Struikmans, H., Rosendaal, F. R., Putter, H., Nortier, J. W. R.
Publicado 2007

Explorative study to identify novel candidate genes related to oxaliplatin efficacy and toxicity using a DNA repair array

por Kweekel, D M, Antonini, N F, Nortier, J W R, Punt, C J A, Gelderblom, H, Guchelaar, H-J
Publicado 2009

GSTP1 Ile105Val polymorphism correlates with progression-free survival in MCRC patients treated with or without irinotecan: a study of the Dutch Colorectal Cancer Group

por Kweekel, D M, Koopman, M, Antonini, N F, Van der Straaten, T, Nortier, J W R, Gelderblom, H, Punt, C J A, Guchelaar, H-J
Publicado 2008

Dose-dense epirubicin and paclitaxel with G-CSF: a study of decreasing intervals in metastatic breast cancer

por Lalisang, R I, Voest, E E, Wils, J A, Nortier, J W, Erdkamp, F L, Hillen, H F, Wals, J, Schouten, H C, Blijham, G H
Publicado 2000

A phase II study of raltitrexed and gemcitabine in patients with advanced pancreatic carcinoma

por Arends, J J, Sleeboom, H P, Leys, M B L, ten Bokkel Huinink, D, de Jong, R S, Smit, J M, Nortier, J W R, Tesselaar, M E T
Publicado 2005

Effects of neoadjuvant chemotherapy with or without zoledronic acid on pathological response: A meta-analysis of randomised trials

por Kroep, J.R., Charehbili, A., Coleman, R.E., Aft, R.L., Hasegawa, Y., Winter, M.C., Weilbaecher, K., Akazawa, K., Hinsley, S., Putter, H., Liefers, G.J., Nortier, J.W.R., Kohno, N.
Publicado 2015

Immunological subtypes in breast cancer are prognostic for invasive ductal but not for invasive lobular breast carcinoma

por Engels, C C, Fontein, D B Y, Kuppen, P J K, de Kruijf, E M, Smit, V T H B M, Nortier, J W R, Liefers, G J, van de Velde, C J H, Bastiaannet, E
Publicado 2014

Using a quality of life (QoL)-monitor: preliminary results of a randomized trial in Dutch patients with early breast cancer

por Lugtenberg, R. T., Fischer, M. J., de Jongh, F., Kobayashi, K., Inoue, K., Matsuda, A., Kubota, K., Weijl, N., Yamaoka, K., Ramai, S. R. S., Nortier, J. W. R., Putter, H., Gelderblom, H., Kaptein, A. A., Kroep, J. R.
Publicado 2020

Cross-cultural comparison of breast cancer patients’ Quality of Life in the Netherlands and Japan

por Fischer, M. J., Inoue, K., Matsuda, A., Kroep, J. R., Nagai, S., Tozuka, K., Momiyama, M., Weijl, N. I., Langemeijer-Bosman, D., Ramai, S. R. S., Nortier, J. W. R., Putter, H., Yamaoka, K., Kubota, K., Kobayashi, K., Kaptein, A. A.
Publicado 2017

Quality of life in relation to tamoxifen or exemestane treatment in postmenopausal breast cancer patients: a Tamoxifen Exemestane Adjuvant Multinational (TEAM) Trial side study

por van Nes, J. G. H., Fontein, D. B. Y., Hille, E. T. M., Voskuil, D. W., van Leeuwen, F. E., de Haes, J. C. J. M., Putter, H., Seynaeve, C., Nortier, J. W. R., van de Velde, C. J. H.
Publicado 2012

CYP2D6 genotype- and endoxifen-guided tamoxifen dose escalation increases endoxifen serum concentrations without increasing side effects

por Dezentjé, V. O., Opdam, F. L., Gelderblom, H., Hartigh den, J., Van der Straaten, T., Vree, R., Maartense, E., Smorenburg, C. H., Putter, H., Dieudonné, A. S., Neven, P., Van de Velde, C. J. H., Nortier, J. W. R., Guchelaar, H.-J.
Publicado 2015

Strong CD8+ lymphocyte infiltration in combination with expression of HLA class I is associated with better tumor control in breast cancer patients treated with neoadjuvant chemoth...

por de Groot, A. F., Blok, E. J., Charehbili, A., Engels, C. C., Smit, V. T. H. B. M., Dekker-Ensink, N. G., Putter, H., Meershoek-Klein Kranenbarg, E., van de Velde, C. J. H., Liefers, G. J., Nortier, J. W. R., Kuppen, P. J. K., van der Burg, S. H., Kroep, J. R.
Publicado 2019

Thyroid function alters during neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01)

por de Groot, S., Janssen, L. G. M., Charehbili, A., Dijkgraaf, E. M., Smit, V. T. H. B. M., Kessels, L. W., van Bochove, A., van Laarhoven, H. W. M., Meershoek-Klein Kranenbarg, E., van Leeuwen-Stok, A. E., van de Velde, C. J. H., Putter, H., Nortier, J. W. R., van der Hoeven, J. J. M., Pijl, H., Kroep, J. R.
Publicado 2015